GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » Sale Of Investment

Fulgent Genetics (MEX:FLGT) Sale Of Investment : MXN8,442 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics Sale Of Investment?

Fulgent Genetics's sale of investment for the three months ended in Dec. 2024 was MXN1,554 Mil. It means Fulgent Genetics gained MXN1,554 Mil from selling investments. Fulgent Genetics's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was MXN8,442 Mil.

Compared with last quarter (MXN2,833 Mil in Sep. 2024 ), Fulgent Genetics gained less money from selling investments in Dec. 2024 (MXN1,554 Mil).

Fulgent Genetics Sale Of Investment Historical Data

The historical data trend for Fulgent Genetics's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Sale Of Investment Chart

Fulgent Genetics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 736.28 5,530.39 7,266.35 9,380.70 9,469.84

Fulgent Genetics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,983.28 2,528.49 1,526.41 2,832.73 1,554.35

Fulgent Genetics Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN8,442 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fulgent Genetics Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » Sale Of Investment
Comparable Companies
CSTL PSNL ATLN STIM MYGN ACRS LDDD GRAL BDSX OCX TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD WAT NTRA
Traded in Other Exchanges
FLGT:USA 7F0:Germany
Address
4399 Santa Anita Avenue, El Monte, CA, USA, 91731
Website
https://www.fulgentgenetics.com
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.